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1. Introduction
Long hairpin motifs composed of N-methylpyrrole (Py) and N-
methylimidazole (Im) recognize and bind DNA in the minor 
groove in a sequence-specific manner. An antiparallel pairing of 
Im opposite Py (Im/Py pair) distinguishes G–C from C–G, 
whereas a Py/Py pair binds both A–T and T–A base pairs.1-6 Py-
Im polyamides have strong DNA binding affinity and sequence 
specificity for target match sequences. Various types of sequence-
specific Py-Im polyamides have been developed to control gene 
expression by competitive binding against DNA-binding proteins 
such as transcription factor.7-18 The introduction of a -alanine 
moiety within the hairpin motif allows the crescent-shaped Py-Im 
polyamides to fit into the minor groove of dsDNA, and antiparallel 
pairings of /, Py/-pair recognize both T–A and A–T.19 In 
general, the -linker was set in the hairpin motif to extend the 
DNA sequence recognition. Although long hairpin Py-Im 
polyamides have interesting biological properties, they tend to 
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have limited aqueous solubility and can precipitate by aggregation 
in the aqueous phase.20 
To address this issue, we investigated the use of the 8-amino-
3,6-dioxaoctanoic acid (AO) unit, which Laemmli et al. originally 
used as a hydrophilic and flexible linker for compounds targeting 
the long satellites I and III and SARs (scaffold associated 
regions).21 Later, they developed Py-Im polyamides with an AO 
linker between the two hairpin motifs for binding insect and 
vertebrate telomeric repeats.22 Recently, our group also reported a 
tandem dimer23 and a tandem trimer that can be used to target 
human telomere sequences.24 However, herein we used the same 
group within hairpin motifs to enhance aqueous solubility.  
To conduct a large-scale evaluation of the DNA-binding 
characteristics of Py-Im polyamides and other DNA-binding 
molecules, Ansari et al. established a cognate site identification 
(CSI) microarray platform and developed a visualization method 
called a sequence-specificity landscape (SSL) display.25-29 
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With the aim of improving aqueous solubility, we designed and synthesized five N-methylpyrrole 
(Py)-N-methylimidazole (Im) polyamides capable of recognizing 9-bp sequences. Their DNA-
binding affinities and sequence specificities were evaluated by SPR and Bind-n-Seq analyses. The 
design of polyamide 1 was based on a conventional model, with three consecutive Py or Im rings 
separated by a -alanine to match the curvature and twist of long DNA helices. Polyamides 2 and 
3 contained an 8-amino-3,6-dioxaoctanoic acid (AO) unit, which has previously only been used 
as a linker within linear Py-Im polyamides or between Py-Im hairpin motifs for tandem hairpin. 
It is demonstrated herein that AO also functions as a linker element that can extend to 2-bp in 
hairpin motifs. Notably, although the AO-containing unit can fail to bind the expected sequence, 
polyamide 4, which has two AO units facing each other in a hairpin form, successfully showed 
the expected motif and a KD value of 16 nM was recorded. Polyamide 5, containing a -alanine-
-alanine unit instead of the AO of polyamide 2, was synthesized for comparison. The aqueous 
solubilities and nuclear localization of three of the polyamides were also examined. The results 
suggest the possibility of applying the AO unit in the core of Py-Im polyamide compounds. 2009 
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Sequence specificities of Py-Im polyamides have also been 
investigated by using high-throughput sequencing.30-32 
Here, we designed and synthesized thirteen Py-Im polyamides 
(Fig. 1) to investigate the utility of the AO unit with respect to 
affinity toward a DNA sequence, sequence specificities of DNA 
binding, aqueous solubilities, and cell permeabilities. Polyamide 1 
is a standard design with one -alanine inserted within the 
structure to relax the distortion between three rings.19 Polyamides 
2 and 3 each has one AO unit in either the N- or C-side strand, 
respectively. Notably, the introduction of the AO unit can decrease 
the number of coupling steps because the moiety covers two base 
pairs. Polyamide 4 has two AO units, one in each strand. To 
examine whether the AO unit can be replaced by a common 
aliphatic combination motif, instead of the AO in polyamide 2, 
polyamide 5 contained one β-alanine-β-alanine unit. Although 
several Py-Im polyamides containing a β-alanine-β-alanine moiety 
within linear motifs have been developed in attempts to alkylate 
human telomere sequences,33, 34 to our knowledge, the group has 
not been used within a hairpin motif. 
First, the KD values of polyamides 1–5 were obtained by SPR 
experiments. Second, the biotinylated polyamides were applied to 
Bind-n-Seq analysis,31 which is a high-throughput technique to 
determine the binding specificities of Py-Im polyamides: 
treatment of ODN containing random sequences by a biotinylated 
Py-Im polyamide of interest; pull-down of the ODN bound by the 
polyamide using magnetic Streptavidin beads; elution and 
amplification; emulsion PCR then sequencing on a chip. Third, 
saturating concentrations for three of the polyamides were 
measured. Finally, the FITC-labeled polyamides were applied to a 
breast cancer cell line, MDA-MB-231, to establish their nuclear 
localization. The inclusion of the AO unit was found to enhance 
the solubility of the polyamide without leading to loss of cell 
permeability; however, it was revealed that DNA-binding affinity 
depended significantly on its position. 
2. Results and Discussion 
2.1. Synthesis of Py-Im polyamides 1–13 
The Py-Im hairpin polyamides 1–5, with an amino group at the 
C-terminus, were prepared by Fmoc solid-phase synthesis starting 
from a Py-coupled oxime resin followed by treatment with 3,3-
diamino-N-methyldipropylamime. The purities and structures of 
Py-Im polyamides 1–5 were confirmed by 1H NMR spectroscopic 
analysis and by electrospray ionization time-of-flight mass 
spectrometry (ESI-TOFMS) after purification by reverse-phase 
flash chromatography. Purified 1–5 were used for SPR assays and 
to evaluate their solubility in aqueous media. Biotin conjugates 6–
10 were synthesized by coupling with PEG-linked biotin N-
hydroxysuccinimide and purified by reverse-phase HPLC for 
Bind-n-Seq. Similarly, fluorescein conjugates 11–13 were 
synthesized by coupling with fluorescein isothiocyanate (FITC) 
and the products were purified by reverse-phase HPLC for cell-
permeability assays. Given that the AO unit can extend to two base 

































Figure 1. Chemical structures of Py-Im polyamides 1–13. 
2.2. Binding affinities of 1–5 determined by SPR analysis 
SPR assays were performed to evaluate the influence on DNA-
binding affinities of Py-Im polyamides 1–5 by the insertion of an 
AO unit. The sequence of the immobilized ODN was 5-biotin 
labeled 
GCGAGGCAGACACGCTTTTGCGTGTCTGCCTCGC-3. 
This sequence was determined based on the top 1 sequence in 
Bind-n-Seq analysis of polyamide 1, which had already been 
elucidated. The sensorgrams of polyamides 1–5 are shown in Fig. 
2, and the rates of association (ka) and dissociation (kd), and the 
dissociation constants (KD) are shown in Table 1. The KD values 
of polyamides 1–5 were 5.9, 18, 250, 16, and 15 nM, respectively. 
Notably, the binding affinity of Py-Im polyamide 1 was the 
strongest. 
One of the reasons why polyamides 2 and 4 had lower affinities 
than polyamide 1 can be the loss of a hydrogen bond. However, 
even though the number of hydrogen bonds of polyamides 1 and 5 
is the same, the affinity of polyamide 1 was higher. This suggests 
that the hydrogen bond is not the only determinant and that excess 
flexibility of the AO or -alanine--alanine moiety may reduce the 
affinity. Although it is difficult to explain the large difference in 
KD between polyamides 2 and 3, the low affinity of the latter was 
recovered by inserting another AO unit to obtain polyamide 4. This 
observation indicates that the affinity of the Py-Im polyamide is 















Figure 2. SPR-binding assays to evaluate the binding properties of polyamides 
1-5. (a) A biotinylated DNA including a target sequence. The target sequence 
for the polyamides is shown in bold. (b) SPR sensorgrams for interactions of 1. 
The concentrations were 100 nM (blue), 85 nM (orange), 70 nM (gray), 55 nM 
(yellow), and 40 nM (dark blue). (c) SPR sensorgrams for interactions of 2. 
The concentrations were 250 nM (blue), 167 nM (orange), 111 nM (gray), 74 
nM (yellow), and 49 nM (dark blue). (d) SPR sensorgrams for interactions of 
3. The concentrations were 250 nM (blue), 200 nM (orange), 150 nM (gray), 
100 nM (yellow), and 50 nM (dark blue). (e) SPR sensorgrams for interactions 
of the 4. The concentrations were 625 nM (blue), 313 nM (orange), 156 nM 
(gray), 78 nM (yellow), and 39 nM (dark blue). (f) SPR sensorgrams for 
interactions of 5. The concentrations were 156 nM (blue), 78 nM (orange), 39 
nM (gray), 20 nM (yellow), and 10 nM (dark blue). 
 
Table 1. The values of the association rates (ka) and dissociation 
rates (kd) obtained from curve fittings of sensorgrams, and 
dissociation constants (KD). 
polyamide 1 [a] 2 3 4 5 
ka [1/Ms] 2.4×10
5 1.0×105 1.0×104 1.8×104 1.3×105 
kd [1/s] 1.4×10
-3 1.8×10-3 4.5×10-3 3.0×10-4 1.9×10-3 
KD [M] 5.9×10
-9 1.8×10-8 2.5×10-7 1.6×10-8 1.5×10-8 
 
2.3. Bind-n-Seq 
For the large-scale analyses of DNA sequence specificities, we 
performed Bind-n-Seq30, 31, 35 experiments with a next-generation 
sequencer, Ion PGM, with a library of oligomers containing 
randomized 21-mer. Polyamides 1–5 were biotinylated for this 
assay to yield polyamides 6–10 by following a previously reported 
procedure.31 
The results revealed sequences pulled down by each polyamide 
6–10; their top-10 sequences in the order of enrichment values are 
shown in Fig. 3 together with their motifs, which were processed 
by using enoLOGOS (http://www.benoslab.pitt.edu/cgi-
bin/enologos/enologos.cgi). 
Generally, polyamides 6, 7, 9, and 10 bind oligomers according 
to their expected sequences (Fig. 3). However, the binding motif 
from polyamide 8 was so unspecific that it even raised doubts 
about its hairpin formation. Nonetheless, the Bind-n-Seq results 
support the results of SPR analysis, which showed that the KD 
value for polyamide 3 was one order of magnitude lower than 
those of polyamides 2, 4, and 5. Again, although it is challenging 
to establish the cause of these differences from these data alone, it 
can be concluded that the position of the AO unit should be 
selected so that it does not disturb the binding to the predetermined 
sequence based on the pairing rules. 
Looking in more detail at the results obtained with polyamide 
9 revealed that the sequences contained an interesting “N (aNy 
base)” at site 5 (Fig. 3d). This phenomenon is easily explained. 
The pairing rules of Py-Im polyamide are based on hydrogen 
bonds formed mainly between amide NH and a proton acceptor of 
the nucleobase in the minor groove. As an antiparallel slipped pair 
of AO units accrues one base pair facing no proton donor, that site 
would be “recognized” as N. This recognition has never been 
reported because it could not be achieved by using the common 
elements in Py-Im polyamide, N-methylpyrrole, N-
methylimidazole, -alanine and -turn. This feature might be 
useful in designing long Py-Im polyamide probes containing a site 
that should accommodate any of the bases. Similar to the results 
obtained by SPR analysis, it is notable that inserting the second 
AO unit in polyamide 8 can lead to a recovery of both sequence 
specificity and DNA-binding affinity. 
Another point that can be noted from the Bind-n-Seq results is 
that site 1 of the binding motif of polyamide 10 (Fig. 3e) had G 
specificity, whereas W (A or T) was expected. It is difficult to 
rationalize this result but -alanine--alanine is the apparent 
trigger for this unfavorable recognition. The result that polyamide 
7 motif demonstrated the expected target sequence might imply an 
advantage of using the AO unit over -alanine--alanine. 
 
 
 Figure 3. Motif analyses, the top 10 sequences pulled down by Bind-n-Seq, and schematic representation of the sequence-specific recognition of conjugate 6 (a), 
7 (b), 8 (c), 9 (d), and 10 (e). 
2.4. Solubility and cell permeability 
Given that one of the motivations for introducing an AO unit 
was to enhance aqueous solubility and to circumvent aggregation 
of Py-Im polyamide in aqueous media, we measured the saturating 
concentration in water as previously reported.36 To this end, an 
aqueous solution (2.0 L) was diluted in DMF (198 L). The 
absorbance of the peak around 310 nm of each sample was 
measured and the concentration of each conjugate was calculated. 
Saturating concentrations of polyamides 1, 2, and 4 were 9.1, 12.2, 
and 13.9 mM, respectively. As expected, the aqueous solubilities 
of polyamides increased as the number of AO units increased. 
Polyamide 3 was excluded from this solubility and cell-
permeability assay because it has exactly the same components as 
polyamide 2 and can be assumed to have nearly the same 
properties. Polyamide 5 was not tested because the aim of this 
study was to investigate the characteristics of AO-incorporating 
Py-Im polyamide 
The situation regarding hydrophilicity is finely balanced: 
whereas poor solubility of Py-Im polyamide is problematic 
because it can lead to the formation of aggregates, high 
hydrophilicity can inhibit cell permeability. We therefore also 
examined the cell permeability of FITC-polyamides 11–13. Thus, 
human breast cancer cells (MDA-MB-231) were cultured and 
FITC-polyamides 11–13 were introduced to the cell. Subsequent 
confocal microscopy studies revealed localized fluorescence as 
shown in Fig. 4 and Fig. S1 (Fig. 4 shows a detailed view of a 
single cell in which FITC-polyamide and Hoechst were 
introduced; Fig. S1 shows the whole pictures). The images 
demonstrate that the nuclear localization of polyamides 12 and 13 


















Figure 4. Confocal images of MDA-MB-231 cells after 72 h incubation. 
 
3. Conclusion 
We have studied the function and effects of incorporating an 
AO unit in hairpin Py-Im polyamides from five types of Py-Im 
polyamide: a normal polyamide 1; polyamides 2 and 3, with one 
AO unit; polyamide 4, with two AO units; and polyamide 5, with 
-alanine--alanine. SPR and Bind-n-Seq analyses revealed that 
polyamides 2 and 7 had a significantly better binding affinity and 
sequence specificity than polyamides 3 and 8, although the 
components of the Py-Im polyamides were same. Notably, 
polyamides 4 and 9 recovered both characteristics and gained an 
unprecedented “recognition” of base N (Fig. 3d). However, it 
became clear that the position of the AO unit affects the DNA-
binding features significantly. Nevertheless, incorporation of an 
AO unit was shown to lead to greater aqueous solubility without 
loss of cell permeability. Thus, the possibility of using the AO unit 
as a linker within long hairpin Py-Im polyamides in biological 




4.1. General information 
The reagents for polyamide synthesis such as Fmoc-Py-OH, 
Fmoc-Im-OH, Fmoc-Py-Im-OH, Piperidine 98%, NMP (Super 
Dehydrated), DMF (for Peptide Synth.) were purchased from 
Wako. Acetic Anhydride (Guaranteed Reagent) was from nacalai 
tesque. Fmoc-β-Ala-COOH and Fmoc-β-Ala-Wang resin (100-
200 mesh) were obtained from Novabiochem. Fmoc-mini-PEGTM 
was purchased from PEPTIDE INTERNATIONAL.   
The reagents for coupling reaction such as Fluorescein-5-
isothiocyanate and DIEA was obtained from TCI, DMF was from 
KANTO CHEMICAL. NHS-PEG12-Biotin was purchased from 
Thermo Scientific. HPLC grade acetonitrile (nacalai tesque) was 
used for both analytical and preparative HPLC. Water was 
prepared by a Milli-Q apparatus (MERCK MILLIPORE). ESI-
TOF MS was performed on a Bio-TOF II (Bruker Daltonics) mass 
spectrometer by using positive ionization mode. NMR spectra 
were recorded on a JEOL JNM ECA-600 NMR spectrometer with 
tetramethylsilane as an internal standard. The following 
abbreviations apply to spin multiplicity: s (singlet), d (doublet), t 
(triplet), m (multiplet) and br (broad). 
4.2. Synthesis of polyamide 1 
Fmoc solid-phase synthesis of Py-Im polyamide was performed 
on a PSSM-8 with a computer-assisted operation system. 56 mg of 
β-Wang resin (0.55 mmol/g) was used on the solid-phase synthesis. 
The resulting crude polyamide (14.4 mg, 7.36 μmol) was purified 
with reversed-phase column chromatography. Purification was 
performed on CombiFrash Rf using a 4.3 g C18 RediSep Rf 
reversed-phase flash column (Teledyne Isco, Inc) with 0.1% TFA 
in water and acetonitrile as the eluent at a flow rate of 18.0 mL/min 
and a linear gradient elution of 0 to 35% acetonitrile from 5 to 40 
min. Collected appropriate fractions were concentrated on an 
evaporator and lyophilized. Then we obtained the polyamide 1 (4.2 
mg, 2.2 μmol, 7.0% yield). Analytical HPLC: tR = 10.4 min (0.1% 
TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-TOFMS m/z 
calcd for C89H113N36O17
3+ [M + 3H]3+ 652.6356, found 652.6333. 
1H NMR (600 MHz, DMSO-d6): δ = 10.31 (s, 1H), 10.29 (s, 2H), 
10.28 (s, 1H), 10.25 (s, 1H), 10.01 (s, 1H), 10.00 (s, 1H), 9.98 (s, 
1H), 9.89 (s, 3H), 9.42 (s, 1H), 8.09 (m, 2H), 8.04 (m, 3H), 7.56 
(s, 1H), 7.49(s, 1H), 7.46 (s, 2H), 7.45 (s, 1H), 7.25 (s, 3H), 7.22 
(s, 1H), 7.18 (s, 1H), 7.16 (s, 1H), 7.15 (s, 1H), 7.12 (m, 3H), 6.97 
(s, 1H), 6.89 (s, 1H), 6.88 (s, 1H), 6.86 (s, 1H), 3.99 (s, 3H), 3.97 
(s, 3H), 3.95 (s, 6H), 3.94 (s, 1H), 3.84 (s, 9H), 3.81 (m, 6H), 3.80 
(s, 6H), 3.19 (m, 4H), 3.13 (m, 4H), 3.05 (m, 4H), 2.86 (s, 2H), 
2.74 (d, J = 4.1 Hz, 3H), 2.59 (m, 4H), 2.36 (m, 4H), 2.04 (s, 3H), 
1.89 (m, 4H), 1.77 (m, 4H). 
4.3. Synthesis of polyamide 2 
Fmoc solid-phase synthesis of Py-Im polyamide was performed 
on a PSSM-8 with a computer-assisted operation system. 49 mg of 
β-Wang resin (0.55 mmol/g) was used on the solid-phase synthesis. 
The resulting crude polyamide (13.2 mg, 6.92 μmol) was purified 
with reversed-phase column chromatography. Purification was 
performed on CombiFlash Rf using a 4.3 g C18 RediSep Rf 
reversed-phase flash column (Teledyne Isco, Inc) with 0.1% TFA 
in water and acetonitrile as the eluent at a flow rate of 18.0 mL/min 
and a linear gradient elution of 0 to 45% acetonitrile from 5 to 50 
min. Collected appropriate fractions were concentrated on an 
evaporator and lyophilized. Then we obtained the polyamide 2 (3.3 
mg, 1.7 μmol, 6.4% yield). Analytical HPLC: tR = 10.3 min (0.1% 
TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-TOFMS m/z 
calcd for C86H113N34O18
3+ [M + 3H]3+ 636.6319, found 636.6272. 
1H NMR (600 MHz, DMSO-d6): δ = 10.31 (s, 1H), 10.28 (s, 1H), 
10.26 (s, 1H), 10.06 (s, 1H), 10.00 (s, 1H), 9.98 (s, 1H), 9.90 (s, 
2H), 9.88 (s, 1H), 9.61 (s, 2H), 9.35 (s, 1H), 8.32 (t, J = 5.5 Hz, 
1H), 8.09 (t, J = 5.5 Hz,1H), 8.04 (m, 3H), 7.51 (s, 1H), 7.48 (s, 
1H), 7.48 (s, 1H), 7.47 (s, 1H), 7.46 (s, 1H), 7.26 (s, 2H), 7.18 (s, 
1H), 7.16 (s, 3H), 7.13 (m, 2H), 7.09 (s, 1H), 6.89 (s, 1H), 6.88 (s, 
1H), 6.87 (s, 1H), 4.11 (s, 2H), 3.97 (s, 3H), 3.96 (s, 6H), 3.95 (s, 
3H), 3.91 (s, 3H), 3.84 (s, 6H), 3.81 (m, 6H), 3.80 (s, 6H), 3.69 (m, 
2H), 3.63 (m, 2H), 3.60 (m, 2H), 3.51 (m, 2H), 3.20 (m, 4H), 3.13 
(m, 2H), 3.06 (m, 4H), 2.86 (s, 2H), 2.74 (d, J = 3.4 Hz, 3H), 2.60 
(m, 2H), 2.36 (m, 4H), 2.03 (s, 3H), 1.92 (m, 2H), 1.79 (m, 4H). 
4.3. Synthesis of polyamide 3 
Fmoc solid-phase synthesis of Py-Im polyamide was performed 
on a PSSM-8 with a computer assisted operation system. 83 mg of 
β-Wang resin (0.55 mmol/g) was used on the solid-phase synthesis. 
The resulting crude polyamide (33.5 mg) was purified with 
reversed-phase column chromatography. Purification was 
performed on CombiFlash Rf using a 4.3 g C18 RediSep Rf 
reversed-phase flash column (Teledyne Isco, Inc) with 0.1% TFA 
in water and acetonitrile as the eluent at a flow rate of 18.0 mL/min 
and a linear gradient elution of 0 to 45% acetonitrile from 5 to 50 
min. Collected appropriate fractions were concentrated on an 
evaporator and lyophilized. Then we obtained the polyamide 3 (6.8 
mg, 3.6 μmol, 7.9% yield). 1H NMR (600 MHz, DMSO-d6): δ 
10.30 (s, 1H), 10.28 (s, 1H) 10.27 (s, 1H), 10.25 (s, 1H), 10.09 (s, 
1H), 9.97 (s, 1H), 9.89 (s, 3H), 9.60 (s, 1H), 9.32 (s, 1H), 8.08 (m, 
3H), 8.02 (m, 2H), 7.56 (s, 1H), 7.503 (s, 1H), 7.499 (s, 1H), 7.46 
(s, 1H), 7.44 (s, 1H), 7.26 (d, 1H, J = 1.4 Hz), 7.22 (d, 1H, J = 1.4 
Hz), 7.20 (s, 2H), 7.17 (s, 2H), 7.15 (d, 1H, J = 2.0 Hz), 7.13 (d, 
1H, J = 1.4 Hz), 6.97 (d, 1H, J = 2.0 Hz), 6.93 (d, 1H, J = 2.0 Hz), 
6.89 (d, 1H, J = 2.0 Hz), 6.88 (d, 1H, J = 2.0 Hz), 4.11 (s, 2H), 
3.99 (s, 3H), 3.98 (s, 3H), 3.96 (s, 3H), 3.95 (s, 3H), 3.93 (s, 3H), 
3.84 (s, 3H), 3.81 (s, 6H), 3.79 (s, 6H), 3.77 (s, 3H), 3.62 (m, 4H), 
3.42 (m, 2H), 3.19 (m, 2H), 3.13 (m, 2H), 3.05 (m, 4H), 2.85 (br, 
2H), 2.74 (d, 3H, J = 4.8 Hz), 2.60 (m, 4H), 2.35 (m, 8H), 2.03 (s, 
3H), 1.88 (br, 2H), 1.78 (m, 4H). ESI-TOFMS: m/z calcd for 
C86H112N34O18
2+: 954.4441 [M + 2H]2+, found: 954.4453; HPLC: 
tR= 17.0 min (0.1% TFA/MeCN, linear gradient 0–50%, 0–20 min). 
4.4. Synthesis of polyamide 4 
Fmoc solid-phase synthesis of Py-Im polyamide was performed 
on a PSSM-8 with a computer assisted operation system. 50 mg of 
β-Wang resin (0.55 mmol/g) was used on the solid-phase synthesis. 
The resulting crude polyamide (14.1 mg, 7.58 μmol) was purified 
with reversed-phase column chromatography. Purification was 
performed on CombiFlash Rf using a 4.3 g C18 RediSep Rf 
reversed-phase flash column (Teledyne Isco, Inc) with 0.1% TFA 
in water with acetonitrile as the eluent at a flow rate of 18.0 
mL/min and a linear gradient elution of 0 to 45% acetonitrile from 
5 to 50 min. Collected appropriate fractions were concentrated on 
evaporator and lyophilized. Then we obtained the polyamide 3 (7.4 
mg, 4.0 μmol, 15% yield). Analytical HPLC: tR = 10.4 min (0.1% 
TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-TOFMS m/z 
calcd for C86H113N34O18
3+ [M + 3H]3+ 636.6319, found 636.6272. 
1H NMR (600 MHz, DMSO-d6):  = 10.31 (s, 1H), 10.25 (s, 1H), 
10.11 (s, 1H), 10.06 (s, 1H), 9.90 (s, 1H), 9.89 (s,1H), 9.88 (s, 1H), 
9.62 (s, 1H), 9.61 (s, 1H), 9.33 (s, 1H), 8.32 (t, J = 6.9 Hz, 1H), 
8.08 (m, 2H), 8.03 (m, 2H), 7.51 (s, 1H), 7.50 (s, 1H), 7.48 (s, 1H), 
7.48 (s, 1H), 7.44 (s, 1H), 7.21 (m, 2H), 7.16 (m, 3H), 7.15 (m, 
1H), 7.09 (m, 1H), 6.93 (m, 1H), 6.89 (m, 2H), 4.11 (s, 4H), 3.97 
(s, 3H), 3.96 (s, 3H), 3.95 (s, 3H), 3.93 (s, 3H), 3.90 (s, 3H), 3.81 
(m, 6H), 3.79 (s, 3H), 3.79 (s, 3H), 3.77 (s, 3H), 3.68 (m, 4H), 
3.62(m, 4H), 3.60 (t, J = 5.5 Hz, 2H), 3.57 (t, J = 6.2 Hz, 2H), 3.51 
(m, 4H), 3.42 (m, 4H), 3.19 (m, 2H), 3.12 (m, 2H), 3.02 (m, 4H), 
2.84 (m, 2H), 2.74 (d, J = 5.5 Hz, 3H), 2.61 (m, 3H), 2.38 (m, 2H), 
2.35 (m, 2H), 2.03 (s, 3H), 1.78 (m, 4H). 
4.3. Synthesis of polyamide 5 
Fmoc solid-phase synthesis of Py-Im polyamide was performed 
on a PSSM-8 with a computer assisted operation system. 80 mg of 
β-Wang resin (0.55 mmol/g) was used on the solid-phase synthesis. 
The resulting crude polyamide (21.8 mg) was purified with 
reversed-phase column chromatography. Purification was 
performed on CombiFlash Rf using a 4.3 g C18 RediSep Rf 
reversed-phase flash column (Teledyne Isco, Inc) with 0.1% TFA 
in water and acetonitrile as the eluent at a flow rate of 18.0 mL/min 
and a linear gradient elution of 0 to 45% acetonitrile from 5 to 50 
min. Collected appropriate fractions were concentrated on an 
evaporator and lyophilized. Then we obtained the polyamide 5 (6.1 
mg, 3.2 μmol, 7.3% yield). 1H NMR (600 MHz, DMSO-d6): δ 
10.39 (s, 1H), 10.28 (s, 1H) 10.27 (s, 1H), 10.25 (s, 1H), 9.98 (s, 
1H), 9.96 (s, 1H), 9.94 (s, 1H), 9.89 (s, 3H), 9.37 (s, 1H), 8.30 (t, 
1H, J = 5.9 Hz), 8.09 (t, 1H, J = 5.9 Hz), 8.04 (m, 4H), 7.50 (s, 
1H), 7.49 (s, 1H), 7.47 (s, 1H), 7.46 (s, 1H), 7.44 (s, 1H), 7.26 (s, 
3H), 7.18 (d, 1H, J = 1.4 Hz), 7.17 (d, 1H, J = 1.4 Hz), 7.16 (d, 1H, 
J = 1.4 Hz), 7.14 (d, 1H, J = 1.4 Hz), 7.13 (d, 2H, J = 1.4 Hz), 6.90 
(d, 1H, J = 2.0 Hz), 6.89 (d, 1H, J = 2.0 Hz), 6.87 (d, 1H, J = 2.0 
Hz), 3.963 (s, 3H), 3.957 (s, 3H), 3.951 (s, 3H), 3.948 (s, 3H), 
3.945 (s, 3H), 3.85 (s, 3H), 3.84 (s, 6H), 3.81 (s, 3H), 3.80 (s, 6H), 
3.42 (m, 2H), 3.39 (m, 2H), 3.34 (m, 2H), 3.20 (m, 2H), 3.13 (m, 
2H), 3.04 (m, 4H), 2.86 (br, 2H), 2.74 (d, 3H, J = 4.8 Hz), 2.61 (m, 
4H), 2.37 (m, 8H), 2.02 (s, 3H), 1.89 (br, 2H), 1.79 (m, 4H). ESI-
TOFMS: m/z calcd for C86H111N35O17
2+: 952.9449 [M + 2H]2+, 
found: 952.9472; HPLC: tR= 16.1 min (0.1% TFA/MeCN, linear 
gradient 0–50%, 0–20 min). 
4.5. Synthesis of polyamide 6 
To a solution of the crude Py-Im polyamide (2.3 mg) in DMF 
(150 μL), DIEA (0.8 μL, 4.7 μmol) and NHS-PEG12-Biotin (4.0 
mg, 4.2 μmol, ThermoScientific) were added. The reaction 
mixture was incubated overnight at room temperature. 
Evaporation of the solvent gave a yellow oil, which was purified 
by PU-2089 Plus HPLC (JASCO) using 10 ID ×150 mm 5C18-MS-
II COSMOSIL Packed Column (Nacalai Tesque, Inc.) with 0.1% 
TFA in water and acetonitrile as the eluent at a flow rate of 3.0 
mL/min and a linear gradient elution to afford the hairpin Py-Im 
Polyamide-biotin conjugate (0.8 mg, 0.29 μmol, 9.3%) as a light 
yellow powder. Analytical HPLC: tR = 18.2 min (0.1% 
TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-TOF-MS m/z 
calcd for C126H177N39O32S
3+ [M + 3H]3+ 927.7787, found 927.7815. 
4.6. Synthesis of polyamide 7 
1.0 mg of polyamide 2 (0.53 μmol) was dissolved in 4.9 μL 
DMF solution of NHS-PEG12-Biotin (0.11 mg/μL, 0.52 μmol in 
4.9 μL), and then 0.53 μL of DIEA (3.1 μmol) was added. After 
the mixture was stirred at r.t. for 2 h, it was triturated with diethyl 
ether and purified by PU-2089 Plus HPLC (JASCO) using 10 ID 
×150 mm 5C18-MS-II COSMOSIL Packed Column (Nacalai 
Tesque, Inc.) with 0.1% TFA in water and acetonitrile as the eluent 
at a flow rate of 3.0 mL/min and a linear gradient elution of 30 to 
50% acetonitrile in 30 min. The collected fractions were 
concentrated on evaporator and lyophilized. Then we obtained the 
polyamide 7 (0.52 mg, 0.18 μmol, 33% yield). Analytical HPLC: 
tR = 11.1 min (0.1% TFA/MeCN, linear gradient 0–50%, 0–20 
min). ESI-TOFMS m/z calcd for C123H181N37O33S
4+ [M + 4H]4+ 
684.0830, found 684.0834. 
4.7. Synthesis of polyamide 8 
2.0 mg of polyamide 3 (1.0 μmol) was dissolved in 9.4 μL 
DMF solution of NHS-PEG12-Biotin (0.10 mg/μL, 1.0 μmol in 9.4 
μL), and then 1.0 μL of DIEA (6.0 μmol) was added. After the 
mixture was stirred at r.t. for 10 min, it was triturated with diethyl 
ether and purified by HPLC to obtain the polyamide 8 (0.3 mg, 0.1 
μmol, 10% yield). Analytical HPLC: tR = 13.1 min (0.1% 
TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-TOFMS m/z 
calcd for C123H180N37O33S
3+ [M + 3H]3+ 911.7750, found 911.7706. 
4.8. Synthesis of polyamide 9 
1.0 mg of polyamide 3 (0.54 µmol) was dissolved in 5.4 μL 
DMF solution of NHS-PEG12-Biotin (0.10 mg/µL, 0.57 µmol), 
and then 0.55 μL of DIEA (3.2 μmol) was added. After the mixture 
was stirred at r.t. for 2 h, it was triturated with diethyl ether and 
purified by PU-2089 Plus HPLC (JASCO) using 10 ID x 150 mm 
5C18-MS-II COSMOSIL Packed Column (Nacalai Tesque, Inc.) in 
0.1 % TFA with water and acetonitrile as the eluent at a flow rate 
of 3.0 mL/min and a linear gradient elution of 30 to 50% 
acetonitrile in 30 min. The collected fractions were concentrated 
on evaporator and lyophilized. Then we obtained the polyamide 9 
(0.5 mg, 0.2 µmol, 35% yield). Analytical HPLC: tR = 11.2 min 
(0.1% TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-
TOFMS m/z calcd for C120H181N35O34S
4+ [M + 4H]4+ 672.0802, 
found 672.0787. 
4.9. Synthesis of polyamide 10 
2.0 mg of polyamide 5 (1.0 μmol) was dissolved in 9.4 μL 
DMF solution of NHS-PEG12-Biotin (0.10 mg/μL, 1.0 μmol in 9.4 
μL), and then 1.0 μL of DIEA (6.0 μmol) was added. After the 
mixture was stirred at r.t. for 40 min, it was triturated with diethyl 
ether and purified by HPLC to obtain the polyamide 10 (0.4 mg, 
0.1 μmol, 10% yield). Analytical HPLC: tR = 12.7 min (0.1% 
TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-TOFMS m/z 
calcd for C123H179N38O32S
3+ [M + 3H]3+ 910.7751, found 910.7645. 
4.10. Synthesis of polyamide 11 
0.90 mg of polyamide 1 (0.46 µmol) and 0.36 mg of 
fluorescein-5-isothiocyanate (0.92 µmol) were dissolved in 6.0 µL 
DMF, and then 0.88 µL of DIEA (0.92 µmol) was added. After the 
mixture was stirred at r.t. for 3 h, it was triturated with diethyl ether 
and purified by PU-2089 Plus HPLC (JASCO) using 10 ID x 150 
mm 5C18-MS-II COSMOSIL Packed Column (Nacalai Tesque, 
Inc.) with 0.1 % TFA in water and acetonitrile as the eluent at a 
flow rate of 3.0 mL/min and a linear gradient elution of 30 to 50% 
acetonitrile in 30 min. The collected fractions were concentrated 
on evaporator and lyophilized. Then we obtained the polyamide 
11 (1.0 mg, 0.43 µmol, 93% yield). Analytical HPLC: tR = 11.4 
min (0.1% TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-
TOFMS m/z calcd for C123H180N37O33S
3+ [M + 3H]3+ 782.3142, 
found 782.3176. 
4.11. Synthesis of polyamide 12 
1.0 mg of polyamide 2 (0.53 µmol) and 0.82 mg of fluorescein-
5-isothiocyanate (1.1 µmol) were dissolved in 6.0 µL DMF, and 
then 0.45 µL of DIEA (1.1 µmol) was added. After the mixture 
was stirred at r.t. for 3 h, it was triturated with diethyl ether and 
purified by PU-2089 Plus HPLC (JASCO) using 10 ID x 150 mm 
5C18-MS-II COSMOSIL Packed Column (Nacalai Tesque, Inc.) in 
0.1 % TFA in water and acetonitrile as the eluent at a flow rate of 
3.0 mL/min and a linear gradient elution of 30 to 50% acetonitrile 
in 30 min. The collected fractions were concentrated on evaporator 
and lyophilized. Then we obtained the polyamide 8 (1.0 mg, 0.44 
µmol, 83% yield). Analytical HPLC: tR = 11.5 min (0.1% 
TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-TOFMS m/z 
calcd for C107H124N35O23S
3+ [M + 3H]3+ 766.3105, found 766.3124. 
4.12. Synthesis of polyamide 13 
1.0 mg of polyamide 4 (0.54 µmol) and 0.21 mg of fluorescein-
5-isothiocyanate (0.54 µmol) were dissolved in 6.0 µL DMF, and 
then 0.23 µL of DIEA (0.54 µmol) was added. After the mixture 
was stirred at r.t. for 2 h, it was triturated with diethyl ether and 
purified by PU-2089 Plus HPLC (JASCO) using 10 ID x 150 mm 
5C18-MS-II COSMOSIL Packed Column (Nacalai Tesque, Inc.) 
with 0.1 % TFA in water and acetonitrile as the eluent at a flow 
rate of 3.0 mL/min and a linear gradient elution of 30 to 50% 
acetonitrile in 30 min. The collected fractions were concentrated 
on evaporator and lyophilized. Then we obtained the polyamide 
13 (0.8 mg, 0.4 µmol, 66% yield). Analytical HPLC: tR = 11.7 min 
(0.1% TFA/MeCN, linear gradient 0–50%, 0–20 min). ESI-
TOFMS m/z calcd for C104H123N33O24S
3+ [M + 3H]3+ 750.3067, 
found 750.3055. 
4.13. SPR binding assays 
SPR experiments were performed on a Biacore X instrument 
(GE healthcare) according to previous reports.37, 38 A biotinylated 
hairpin DNA was purchased from JBioS and its sequence is shown 
in Figure 2a. The biotinylated DNA was immobilized to a 
streptavidin-functionalized SA sensor chip to obtain the desired 
immobilization level (approximately 900 RU rise). SPR 
measurements were carried out using degassed and filtered HBS 
buffer (10 mM HPES pH 7.4, 150 mM NaCl, 3 mM EDTA and 
0.005% Surfactant P20) with 0.1% DMSO at 25°C. A series of 
sample solutions with a wide range of concentrations were 
prepared in the buffer with 0.1% DMSO and injected at a flow rate 
of 20 µL/min. Optimized concentration range was then selected 
for the subsequent quantitative analysis. The resulting 
sensorgrams were fitted with 1:1 binding fitting model using 
BIAevaluation 4.1 program in order to obtain the values of binding 
affinities (KD) and kinetics parameters (ka and kd). 
4.14. Bind-n-Seq Analysis 
Bind-n-Seq analysis were proceeded as previously reported.31 
Briefly, oligonucleotides consisting of Ion torrent sequencing 
library adaptor A1, Ion Express Barcode, 21-mer randomized 
sequence and another adaptor P1 were purchased from Sigma-
Aldrich and duplexed via primer extension; 50 nM of Py-Im 
polyamide-biotin conjugates were allowed to bind 1.5 μM of the 
library in 50 μL for 16 h at rt; enrichment by Streptavidin M-280 
Dynabeads and elution from on the beads; PCR amplification, 
quantification by 2100 Bioanalyzer (Agilent Technologies) and 
emulsion PCR on Ion OneTouch 2 system (Thermo Fisher 
Scientific); sequencing by Ion Torrent PGM 318 chip (Thermo 
Fisher Scientific). The results were primarily analyzed by Bind-n-




4.15. Measurement of aqueous solubility 
Saturated solutions of a polyamide 1, 2 and 3 in Milli-Q were 
prepared. The solution (2.00 μL) was diluted in DMF (198 μL). 
The absorbance of the peak around 310 nm of each sample was 
measured and concentration of each conjugate was calculated. 
Absorbance was measured with Nanodrop 1000 (LMS, Inc). 
Molar extinction coefficients ε of Py-Im polyamides in DMF 
solution at around 305 nm were calculated as follows:43 
ε = 9900 × (sum number of P and I) 
Concentrations of Py-Im polyamides were determined by the 
Lambert-Beer law. 
Abs =εcl 
where Abs, c and l are absorbance, molar concentration and the 
path length, respectively. 
4.16. Cell culture and confocal microscopy11, 41 
MDA-MB-231 human breast cancer cell line was purchased 
from European collection of cell cultures and maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS), 100 U/mL penicillin, and 100 
μg/mL streptomycin at 37 °C in humidified atmosphere of 5% CO2.  
Each MICRO COVER GLASS (MATSUNAMI, Inc) was 
coated by 500 µL of StemSure 0.1 w/v % Gelatin Solution (Wako, 
Inc) before seeding. Cells were seeded at a final density of 5 x 103 
cells on each cover glass in a 24-well plate and precultured for 24 
h at 37 °C. After the medium was replaced with a fresh one 
containing 0.5% DMSO and FITC polyamides (340 nM), the cells 
were incubated for 48 h at 37 °C. Each well was then washed twice 
with 500 µL of PBS to remove the excess compound. Hoechst 
33342 (5 µM) was added to the medium 1 h before the PBS 
washing. After that, the cells were fixed by 480 µL 3.5% 
formaldehyde solution (SIGMA ALDLICH) in each well for 20 
min, and washed by 500 µL of PBS twice for 20 min. After that, 
the cover glass was mounted in FLUOROMOUNT/PLUS 
(COSMO BIO CO., LTD) and sealed with a nailpolish. Imaging 
was performed with FV1200 Laser Scanning Microscopes 
(OLYMPUS, Inc). FITC-Polyamide 11-13 were excited using 473 
nm laser at 6% transmissivity with a pinhole of 80 µm and a 
standard fluorescein filter set. Hoechst was excited using 405 nm 
laser lines at 10% transmissivity with pinhole of 80 µm. Image 
analysis was performed using FV10-ASW. PMT voltage in the 
observation of 11 is 424 V on Hoechst, 363 V on fluorescein, 86 
V on DIC. PMT voltage in the observation of 12 is 501 V on 
Hoechst, 430 V on fluorescein, 100 V on DIC. PMT voltage in the 
observation of 13 is 478 V on Hoechst, 473 V on fluorescein, 105 
V on DIC. Objective lens magnification is 20X. 
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